Evidence-Based Reviews

Top research findings of 2018-2019 for clinical practice

Author and Disclosure Information

 

References

Conclusion

  • This small study found a significant decrease in the antidepressant effect of ketamine infusion in patients with TRD when opioid receptors are blocked with naltrexone prior to infusion, which suggests opioid receptor activation is necessary for ketamine to be effective as an antidepressant.
  • This appears to be consistent with observations of buprenorphine’s antidepressant effects. Caution is indicated until additional studies can further elucidate the mechanism of action of ketamine’s antidepressant effects (see "Ketamine/esketamine: Putative mechanism of action," page 32).

4. Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018;5(12):975-986.

Posttraumatic stress disorder (PTSD) is a common and important public health problem. Evidence-based treatments for PTSD include trauma-focused therapies such as prolonged exposure therapy (PE). However, some patients may not respond to PE, drop out, or elect not to pursue it. Researchers continue to explore treatments that are non-trauma-focused, such as mindfulness meditation and interpersonal psychotherapy. In a 3-group comparative effectiveness trial, Nidich et al4 examined the efficacy of a non-trauma-focused intervention, transcendental meditation (TM), in reducing PTSD symptom severity and depression in veterans.

Study design

  • Researchers recruited 203 veterans with PTSD from the Department of Veterans Affairs (VA) San Diego Healthcare System between June 2013 and October 2016.
  • Participants were randomly assigned to 1 of 3 groups: 68 to TM, 68 to PE, and 67 to PTSD health education (HE).
  • Each group received 12 sessions over 12 weeks. In addition to group and individual sessions, all participants received daily practice or assignments.
  • The Clinician-Administered PTSD Scale (CAPS) was used to assess symptoms before and after treatment.

Outcomes

  • The primary outcome assessed was change in PTSD symptom severity at the end of the study compared with baseline as measured by change in CAPS score.
  • Transcendental meditation was found to be significantly non-inferior to PE, with a mean change in CAPS score of −16.1 in the TM group and −11.2 in the PE group.
  • Both the TM and PE groups also had significant reductions in CAPS scores compared with the HE group, which had a mean change in CAPS score of −2.5.

Continue to: Conclusion

Pages

Recommended Reading

Depression linked to persistent opioid use after hysterectomy
MDedge Psychiatry
Black-box warnings: How they can improve your clinical practice
MDedge Psychiatry
ACGME deepening its commitment to physician well-being, leader says
MDedge Psychiatry
Higher risk of bipolar disorder, depression, anxiety found with autism
MDedge Psychiatry
FDA fast-tracks psilocybin for major depressive disorder
MDedge Psychiatry
Fast-tracking psilocybin for refractory depression makes sense
MDedge Psychiatry
Brains of MDD patients show alterations in areas tied to positive emotions
MDedge Psychiatry
Clinic goes to bat for bullied kids
MDedge Psychiatry
Heart rate changes during sleep may be diagnostic tool for depression
MDedge Psychiatry
Novel analysis links insomnia to first-onset major depressive disorder
MDedge Psychiatry